Ang II, ACE2 and Ang (1-7) on the expression and significance of inflammatory bowel disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027511

Enrollment

Unknown

Registered

2019-11-17

Start date

2017-10-01

Completion date

Unknown

Last updated

2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease

Interventions

UC activity group:Ni

UC remission group:Nil

CD activity group:Nil

CD remission group:Nil

Control group:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The included diagnostic criteria for UC and CD patients were all based on the consensus opinions on diagnosis and treatment of inflammatory bowel disease (2012 Guangzhou) formulated by inflammatory bowel disease group, gastroenterology branch, Chinese medical association.The control group was the patients who underwent physical examination in the First Affiliated Hospital of Zhejiang Chinese Medical University during the same period, whose age and gender were matched with IBD patients.

Exclusion criteria

Exclusion criteria: Patients complicated with autoimmune diseases, neoplasia diseases, infectious diseases, severe cardiopulmonary and other organic diseases, taking ACEI/ARB drugs, having a history of acute infectious gastroenteritis within the past 1 month and failing to express it properly and cooperating with the examination.

Design outcomes

Primary

Measure	Time frame
ACE2;Ang II;Ang 1-7;	—

Countries

China

Contacts

Public ContactLi'na Meng

the First Affiliated Hospital of Zhejiang Chinese Medical University

mln6713@126.com+86 13858126713

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026